EARLY DETECTION OF PREECLAMPSIA
DIANEONATAL®
Early risk evaluation enables the identification of pregnant women at increased risk in order to monitor them and provide preventive strategies.
Gynecology
DIANEONATAL®
DIANEONATAL® POCT
DIAGENICS Group SE
DIANEONATAL® ELISA
DIAGENICS Group SE
DIANEONATAL® READER
DIAGENICS Group SE
DIAGENICS has patent-protected antibodies to this enzyme and has already developed a new product line for early diagnosis of preeclampsia: DIANEONATAL.®Current and future studies will further expand our expertise in the field of preeclampsia diagnosis.